Sanofi partners up for 'organ on a chip'; Relmada hauls in $8M;

@FierceBiotech: Most popular story on our website in Sept.: In big setback, GlaxoSmithKline's cancer immunotherapy MAGE-A3 flunks PhIII goal. Story | Follow @FierceBiotech

@JohnCFierce: Pretty clear that Perlmutter now becomes the head wheeler dealer at Merck. Good role for him. Buying and selling. | Follow @JohnCFierce

@DamianFierce: Amid all this talk of axing jobs, have a look at FierceBiotech's rundown of just how much R&D chiefs get paid. Top 15 highest paid biopharma R&D chiefs | Follow @DamianFierce

> Sanofi ($SNY) has united with New Jersey's HμREL to develop "organ on a chip" technology for preclinical research. Article

> Relmada Therapeutics landed an $8 million Series A to fund its pipeline of chronic pain treatments. News

> Texas' Lexicon Pharmaceuticals ($LXRX) posted positive proof-of-concept results for LX4211, a drug designed to treat renal impairment in patients with Type 2 diabetes. More

Medical Device News

@FierceMedDev:  | Follow @FierceMedDev

@MarkHFierce: Two U.S. insurers will now cover MDxHealth's prostate cancer Dx test--a major win. It's hard to get coverage. Press release | Follow @MarkHFierce

@MichaelGFierce: MIT nanoparticles help deliver vaccines to mucosal surfaces. More from FierceDrugDelivery | Follow @MichaelGFierce

> PerkinElmer expands MA life sciences research presence. Article

> Report: Blackstone, Bain, other equity firms bid for J&J's Dx unit. More

Pharma News

@FiercePharma: It's official: Roche's Perjeta nabs speedy  nod in early breast cancer. Kadcyla next? Story | Follow @FiercePharma

@CarlyHFierce: Bristol-Myers melanoma drug Yervoy helps patients live years longer, study finds. ICYMI yesterday | Follow @CarlyHFierce

> Lilly fails to persuade Medicare to pay for Alzheimer's imaging drug. More

> FDA approves Lundbeck, Takeda antidepressant Brintellix. Article

> Merck to slash 8,500 jobs in $2.5B global overhaul. Story

Biotech Research News

@EmilyMFierce: What happens to the FDA in a government shutdown? ICYMI from FierceBiotech | Follow @EmilyMFierce

> New approach could treat common childhood brain cancer. Report

> Antidepressants could provide new way to treat deadly lung cancer. More

> Antifungal drug abolishes HIV in cells. Article

> New approach could treat common childhood brain cancer. Story

> Evolva in talks with U.S. government for $14.7M antibacterial contract. Item

Pharma Manufacturing News

@EricPFierce: Growing Bayer HealthCare gets new leader. Pfizer exec Olivier Brandicourt takes over top job Nov. 1. ICYMI from FiercePharma | Follow @EricPFierce

> Legislation defines when FDA can take action against compounders. Story

> GSK opens $40M plant in Cork, Ireland, adding 20 jobs. More

> Merck joins Bahrain venture. News

> FDA plant inspections continue, even in government chaos. Item

> Boehringer Ingelheim Shanghai plant tripling capacity. Article

And Finally... What happens to science and technology during a government shutdown? Feature

Suggested Articles

Karen DeSalvo's appointment is the latest in a string of hires that deepen the tech giant’s investment in and focus on healthcare.

Spring Bank’s hepatitis B drug, given in tandem with Gilead’s Vemlidy, tamped down on chronic disease in 23% of patients in a phase 2 study.

Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.